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Purpose: Although cigarette smoking remains the most common risk factor for heart disease among the young,
few studies have explored the relationship of smoking with heart disease mortality risk among young people.
This prospective study assesses the risk and burden of all heart disease (HD) and coronary heart disease (CHD)
mortality associated with smoking among younger adults from a nationally representative sample of the
United States.
Method: National Health Interview Survey respondents’ data from 1997–2004 were linked to their death records
through 2006. The analyses were restricted to individuals 18 to 44 years of age during follow up (n = 121,284). Cox
proportional hazard ratios (HR) were estimated with adjustment for sample weights and design effects. Attributable
fractions (AF) of smoking were calculated.
Results: After controlling for age, race, body mass index, history of hypertension and diabetes, and leisure time
physical activity, current smoking related CHD mortality HR was 14.6 [95 % confidence interval or CI, 3.3–64.9]
for females and 3.6 [95 % CI, 1.2–10.4] for males. The HR for all HD mortality was 3.1 [95 % CI, 1.3–7.6] for
females and 2.4 [95 % CI, 1.2–4.7] for males. The AF of smoking for CHD deaths for female and male were 0.58
and 0.54 respectively. The AF of all HD mortality was 0.31 for male and 0.32 for female. The mean estimates of
all HD deaths attributable to smoking during 1997–2006 among this age group were 52,214, of which 45,147
were CHD deaths.
Conclusion: Even after adjustment for multiple risk factors and without addressing passive smoking, our result
showed a strong relationship between smoking and HD and CHD mortality among young adults that is likely causal.
Keywords: Smoking, Younger adults, Mortality, Heart diseaseBackground
In the United States (U.S.), heart disease (HD) ranks the
first among the leading causes of death [1]. This is also
the most costly disease and the cost is increasing with
time. The estimated health care spending and lost prod-
uctivity from morbidity and mortality of heart diseases
including coronary heart disease (CHD) rose from $258
billion in 2006 to $316 billion during 2010 [2]. It is* Correspondence: rjkhan@ucdavis.edu
1Graduate group in Epidemiology, University of California, 5215 VM3A, One
Shields Avenue, Davis, CA 95616, USA
2National Human Genome Research Institute, Genomics of Metabolic,
Cardiovascular and Inflammatory Disease Branch, Social Epidemiology
Research Unit, 10 Center Drive, Bethesda, MD, USA
Full list of author information is available at the end of the article
© 2015 Khan et al. This is an Open Access arti
(http://creativecommons.org/licenses/by/4.0),
provided the original work is properly credited
creativecommons.org/publicdomain/zero/1.0/projected that this cost may triple by the year 2030 [3].
The onset of HD particularly among younger adults can
have particularly high costs. Because people in this age
range are in the prime of their most productive years,
the consequences of HD are clinically and financially
significant, including premature death or disability, loss
of employment, and reduced quality of life. The incident
rate of HD may be lower at younger age, but HD diag-
nosed at early stage of life has an overall poor prognosis
[4]. Moreover, young people are less likely to seek med-
ical care and thus, asymptomatic cases of HD might be
missed. This leads to a possibility that the prevalence of
HD could be grossly underestimated among this group
and the patients who seek medical attention due tocle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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berg”. Many investigators have identified current smok-
ing as the single factor most strongly associated with all
HD and specifically, CHD events among young individ-
uals [5–7]. These studies reported that between 76 %
and 90 % of young patients with CHD are smokers com-
pared with 40 % of older patients [5–7]. Young patients
are also characterized by lower proportion of hyperten-
sion, diabetes mellitus and lipid disorders, but higher
proportion of heavy smoking [5].
Although cigarette smoking remains the most com-
mon risk factor for CHD among the young, few studies
have explored the relationship of smoking with heart
disease mortality risk among young people. Most studies
done in this area are cross sectional or case control
studies [8–11] with a few prospective ones [4, 12]. It is
worth noting that most of these studies had non-fatal
CHD as the outcome measure and thus mortality has
not been definitively reported in a large series or from a
representative sample. Mortality from all kind of HD is
also absent from the current literature. We have tried to
address these issues and the objective of this paper was
to assess the risk and burden of all HD and CHD mor-
tality associated with smoking among younger adults
(18–44 years) from a nationally representative U.S.
sample.
Methods
Data for this analysis were pooled and combined from
the 1997–2004 administrations of the National Health
Interview Survey (NHIS). Details on the survey methods
are available at the NHIS website [13, 14]. In short, the
NHIS is an annual, cross-sectional household survey
conducted by the Centers for Disease Control and Pre-
vention, National Center for Health Statistics (NCHS)
and is representative of the civilian non-institutionalized
population of the U.S. [13, 14]. To achieve sampling effi-
ciency, the NHIS survey uses complex, multistage prob-
ability sample design that incorporates stratification,
clustering and oversampling of certain subgroups. The
first stage of sampling involves dividing the U.S. into ap-
proximately 1,900 geographically defined areas called
Primary Sampling Units (PSU). PSUs are grouped into
strata using social and demographic characteristics of
the area. One or more PSUs are sampled per stratum,
with the probability of selection for each PSU being pro-
portional to its population size within strata. In the next
stage of sampling, a selection of geographic area seg-
ments is sampled from within each selected PSU. These
segments are then subdivided into clusters, each of
which contains a small number housing units. All house-
holds are then assigned a quarter of the year for inter-
view and eligible members of these sampled households
are invited to participate in the basic survey interview.We obtained information on participant’s demographic
factors, race, body mass index or BMI (calculated as
weight in kilograms divided by height in meters
squared), smoking history (smoking behavior, age first
smoked regularly and cigarettes per day), physical activ-
ity level, personal history of CHD risk factors like dia-
betes and hypertension from the “Sample Adult Core
Questionnaire”, which was administered to one ran-
domly selected adult (aged ≥18 years) from each family
within a household. These data are publicly available at
the NHIS websites [13–15]. We combined 8 years of
NHIS (1997–2004) data and linked them with their death
records available at National Death Index database, which
provided mortality follow-up data from the date of the
NHIS interview through December 31, 2006 [16–17].
To know about their smoking status, all the NHIS re-
spondents were asked, “Have you smoked ≥100 ciga-
rettes in your entire life?” and “Do you now smoke
cigarettes every day, some days, or not at all?” Smokers
were defined as those who had smoked ≥100 cigarettes
during their lifetime. Current smokers were defined as
smokers who reported smoking every day or some days.
Past smokers were smokers who reported that they did
not currently smoke. Those who didn’t smoke ≥100 cig-
arettes in their entire life were considered as never
smokers. Thus, smokers were classified as never, current
and past with never smokers being the reference. To get
adequate cell counts for CHD deaths, smokers were also
categorized as current and non-current smokers where,
non-current smokers included never smokers plus past
smokers. Mortality was categorized as all HD mortality
and CHD mortality. NCHS cause of death coding for all
U.S. deaths used the 10th revision of the International
Statistical Classification of Diseases, Injuries, and Cause
of Death (ICD-10) starting in 1999. Cause of death cod-
ing for all U.S. deaths occurring prior to 1999 follows
the 9th revision (ICD-9) [17–19]. However, a new variable
was created by NHIS as a recode of all deaths occurring
prior to 1999 coded under ICD-9 guidelines into compar-
able ICD-10 based underlying cause of death groups. This
variable was used to identify heart disease deaths. All HD
mortality codes were I00 to I09, I11, I13, I20 to I51, and
CHD mortality codes were I20 to I25 [17–19].
The analyses were restricted to individuals ≥18 years
at the cohort entry and no more than 44 years of age at
the end of follow up (participant’s death, turning 44 or
December 2006, whichever came first). The analyses
were further restricted to the participants with available
smoking status and death code information. A total of
130,908 adults (aged 18–44 years) were interviewed dur-
ing the NHIS survey years 1997 through 2004. Partici-
pants who were ineligible for mortality linkage (n =
8431), who didn’t have information on interview quarter
(n = 559), who were unsure about their smoking status
Table 1 Characteristics of adults aged 18–44 years by gender in
the United States: National Health Interview Survey, 1997-2004
Characteristicsa Male Female Total
(NA = 55,200) (NA = 66,084) (NA = 121,284)
(Nw= 53,135,392) (Nw= 53,069,053) (Nw =106,204,445)
Age (In years)b 31.8 (31.7–31.9) 31.7 (31.6–31.8) 31.8 (31.7–31.9)
Race
White 81.0 78.6 79.8
Black 11.8 14.2 13.0
Others 7.2 7.2 7.2
Known Hypertension 10.4 9.9 10.1
Known Diabetes 1.8 2.0 1.9





Never 57.5 62.1 59.8
Past 13.7 13.0 13.3
Current 28.9 24.9 26.9
Age first smoked
regularly (years)b,d
17.1 (17.0–17.1) 17.0 (17–17.1) 17.0 (17.0–17.1)
Cigarettes per dayb 15.5 (15.3–15.8) 13.6 (13.4–13.8) 14.6 (14.5–14.8)
Abbreviation: BMI, Body mass index
NA: Actual N or Actual sample in the data; Nw: Weighted N or weighted/
estimated sample after adjustment for sample weights and design effects
aData represent percentage, except where noted
bMean (95 % Confidence interval)
cCalculated as weight in kilograms divided by height in meters squared
dFor past and current smokers
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codes (n = 18) were excluded from the analysis. The final
data set included 121,284 participants, with 625,743
person-years (male 280,354 and female 345,389).
Statistical Analysis
Analyses were done with adjustment for sample weights
and design effects using the Stata statistical package to
produce nationally representative results. The years be-
ing pooled (1997–2004) fell within the same sample de-
sign period with the same public use design variables,
and according to the analytical guideline no changes
were made to the design variables (Stratum and PSU)
during this time period [18]. The pooled data were
treated like one year of data with a very large sample
size. The new eligibility adjusted sample weights pro-
vided on the NHIS Linked Mortality Files were used to
prevent biased mortality estimates [19]. According to the
recommendation of NCHS, sample weight adjustment of
the pooled data set was done by dividing each sample
weight in the pooled dataset by the number of years that
are being pooled [19]. As eight (1997–2004) survey years
of the NHIS data files were pooled, each sample weight
was divided by eight for analysis purposes.
Descriptive statistics were used to summarize the char-
acteristics of U.S. young adults in relation to their gen-
der. For all other analyses, Cox proportional hazard
analyses were performed using the Stata survival proced-
ure. Person-time of follow-up accrued from the time
interviewed through either the time of the death or the
end of follow-up (December 31, 2006), whichever came
first. Sex-specific and age-adjusted hazard ratio (HR) es-
timates and corresponding 95 % confidence intervals (CIs)
of all HD and CHD disease deaths were reported for
current and past smokers compared to never smokers. The
same analyses were done to obtain the HR for the current
smokers compared to non-current smokers (never plus
past smokers). All multivariate models were adjusted for
age in years, race (White, Black and others), BMI (con-
tinuous), history of hypertension (no/yes) and diabetes
(no/yes), and leisure time physical activity (no physical
activity/leisure-time physical activities for at least
10 min).
We calculated the smoking attributable fraction
(SAF) of current smoking for all HD and for CHD by
using the formula, [(HRc-1)*prevalence current smoking]/
[1+ {(HRc-1)*prevalence current smoking], where HRc =
Hazard for current smoking [20]. The number of all HD
and CHD deaths attributable to smoking in the U.S. popu-
lation in the specified time period (1997–2004) was then
estimated by multiplying the crude SAF by the total num-
ber of deaths of the specified age group (18–44 years) in
the population during that time. Information on the
prevalence of current smoking and the number of totaldeaths in age group 18–44 years for calculating SAF and
deaths attributable to smoking were obtained of from the
nationally published data sources [21–23].
Results
Selected gender specific characteristics and smoking
behaviour of the weighted study population of adults
aged 18–44 years (n =121,284; representing an esti-
mated 106 million young adults) in the NHIS from
1997 to 2004 are shown in Table 1. The mean age of
the total population was 31.8 years at the interview and
was similar for both males and females. The majority of
U.S. young adults were white (79.8 %), which was
slightly higher among males (81.0 %) than females
(78.6 %). Prevalence of hypertension was slightly higher
among males (10.4 %) than females (9.9 %). On the
other hand, prevalence of diabetes was a little higher
among females (2.0 %) than males (1.8 %). Females had
somewhat lower BMI (mean, 25.8 and SE, 0.04) than
males (mean, 26.8 and SE, 0.03) and they were also less
physically active during leisure time than males (female,
64.9 % and male 69.9 %). The prevalence of current
smoking was 28.9 % in men and 24.9 % in women.
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men and women (men, 17.1 years and women, 17.0 years).
The mean number of cigarettes smoked per day were
higher among males (15.5, 95 % CI, 15.3–15.8) compared
to females (13.6, 95 % CI, 13.4–15.8).
Results from the unadjusted and adjusted proportional
hazards models for the risk of all HD and CHD mortality
by smoking status (current and past smokers compared
with reference group never smokers) are presented in
Table 2. The multivariate model adjusted for age (years),
race, history of hypertension, diabetes, BMI, and physical
activity level showed that for all kinds of HD, female
current smokers had a 4.4 [95 % CI, 1.7–11.7]) times
greater risk of mortality compared to female never
smokers and male current smokers had a 2.7 [95 % CI,
1.3–5.2]) fold increased risk compared to male never
smokers. Female past smokers had a 3-fold increased risk
of all HD mortality (HR, 3.4 [95 % CI, 0.9–12.9]) com-
pared with female never smokers, but the p-value was onlyTable 2 Gender specific all heart disease and coronary heart
disease mortality by smoking statusa among adults aged
18–44 years in the United States: National Health Interview










No. of deaths 21 12 7 3c
Current Smoker
No. of deaths 34 22 22 13
Crude HR 3.2 4.8 7.7
95 % CI 1.8–5.7 2.1–10.7 3.1–19.5
Age adjusted HR 3.0 4.5 7.3
95 % CI 1.7–5.5 2.1–10.0 2.9–18.3
Mutivariate HRb 2.7 4.4 5.3
95 % CIb 1.3–5.2 1.67–11.7 2.0–14.7
Past Smoker
No. of deaths 6 6 2c 3c
Crude HR 2.1 3.1 3.7
95 % CI 0.7–6.1 0.9–10.3 0.7–20.1
Age adjusted HR 1.7 2.5 2.8
95 % CI 0.6–4.6 0.8–8.2 0.5–14.45
Mutivariate HRb 1.6 3.4 3.2
95 % CI 0.5–5.4 0.9–13.0 0.6–17.6
Abbreviations: HD, Heart disease; CHD, Coronary heart disease; Ref, reference
group; HR, hazard ratio; CI, confidence interval; No, number
Actual number of death from all causes for never, current and past smokers
were 343. 367 and 102 respectively
aSmoking status categorized as never, current and past smokers
bAdjusted for age (years), race, history of hypertension, diabetes, body mass
index, and physical activity level
cthere were too few CHD deaths in females in categories of never smoker and
past smoker to estimate HR and categories of never smoker and past smoker
were collapsed in subsequent analysismarginally significant (p = 0.07). No significant risk was
found for male past smokers (HR, 1.6 [95 % CI, 0.5–5.4]).
Male current smokers had a 5 fold increased risk of CHD
mortality (HR, 5.3 [95 % CI, 2.0–14.7]) compared to male
never smokers; the risk was also more than 3 times higher
for male past smokers (HR, 3.2 [95 % CI, 0.6–17.6]), but it
was not statistically significant (p = 0.17).
As there were a small number of CHD deaths in never
and past smoker categories, they were combined and clas-
sified as non current smokers to provide more statistically
valid and reliable HR estimates for current smokers
(Table 3). Compared with the female non current smokers,
the female current smokers had more than three times
increased risk of dying from all HD (HR, 3.1 [95 % CI,
1.3–7.6]) and male current smoker had a 2.5 times in-
creased risk of the same compared with male non current
smokers (HR, 2.4 [95 % CI, 1.2–4.7]). The hazard of dying
from CHD was much higher among female current
smokers (HR, 14.6 [95 % CI, 3.3–64.9]) than female non
current smokers. But our finding was somewhat limited by
the fact that we had a small number of female deaths (6
deaths) in non current smokers, which was evident by our
wide confidence interval.
Table 4 shows the crude and adjusted SAF of current
smoking for males and females. The crude SAF for all
HD deaths for current smoking were 0.31 for male and
0.32 for female, meaning that these were the estimated
proportion of all HD death attributable to current
smoking for males and females respectively. The SAF
for CHD deaths were 0.54 for males and 0.58 for fe-
males. The mean estimate of all HD and CHD deaths
in the U.S. attributable to smoking during 1997–2004Table 3 Gender specific all heart disease and coronary heart
disease mortality by smoking statusa among adults aged
18–44 years in the United States: National Health Interview









Non current Smoker (ref)
No. of deaths 27 18 9 6
Current Smoker
No. of deaths 34 22 22 13
Crude HR 2.7 3.6 5.3 10.4
95 % CI 1.5–4.7 1.8–7.3 2.1–13.2 2.9–24.2
Age adjusted HR 2.7 3.5 5.3 9.9
95 % CI 1.5–4.7 1.7–7.1 2.1–13.3 2.7–22.8
Mutivariate HRb 2.4 3.1 3.6 14.6
95 % CI 1.2–4.7 1.3–7.6 1.2–10.4 3.3–64.9
Abbreviations: HD, Heart disease; CHD, Coronary heart disease; Ref, reference
group; HR, hazard ratio; CI, confidence interval; No, number
aSmoking status categorized as current and non-current smokers
bAdjusted for age (years), race, history of hypertension, diabetes, body mass
index and physical activity level
Table 4 Smoking Attributable Fraction (SAF) for current
smoking and estimated numbers of deaths of all heart disease
and coronary heart disease mortality among adults aged 18–44
years in the United States: National Health Interview Survey,









Crude SAF 0.31 0.32 0.54 0.58
Age adjusted SAF 0.31 0.32 0.54 0.56
Multivariate SAFa 0.27 0.28 0.41 0.71
Estimated deathsb 36,833 15,381 33,538 11,609
Abbreviations: HD, Heart disease; CHD, Coronary heart disease; SAF, Smoking
Attributable Fraction
aAdjusted for age (years), race, history of hypertension, diabetes, body mass
index, and physical activity level
bThe number of all HD and CHD deaths attributable to smoking in the U.S.
population was estimated by multiplying the crude SAF by the total number
of deaths of the specified age group in the population during that time
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and 36,833 male) and 45,147 (11,609 female and 33,538
male) respectively .
Discussion
We have documented here the risk and burden of HD
mortality associated with smoking among adults aged
18–44 years from a nationally representative U.S. sam-
ple. After the adjustment for important confounding fac-
tors, the risk of dying from all HD for both, female
current smokers and male current smokers were signifi-
cantly higher than never smokers. This risk was almost
similar when current smokers were compared to non
current smokers. Like all HD, the risk of dying from
CHD for female current smokers and male current
smokers were also significantly higher than non current
smokers. The prevalence of current smoking in age
group 18–44 years during the years 1997–2004 was
26.87 % in our analysis. Though the prevalence showed
a decrease in more recent years, it had always remained
higher for younger age group than older group of people
[21]. Smoking in young people was linked to the devel-
opment of central adiposity and poor dietary patterns
[24]. More importantly, it is believed that, specifically
among the young, smoking can trigger CHD in indi-
viduals with minimal atherosclerosis or even with nor-
mal coronary arteries [25, 26]. All these factors together
make young current smokers more vulnerable to cardio-
vascular diseases. Several studies also strongly suggest
that amongst the conventional cardiovascular risk fac-
tors, current smoking is the most significant discriminat-
ing factor for HD among young adults [5–7].
In our study, the adjusted risk for all HD deaths were
more than 2 fold and more than 4 fold higher in male and
in female current smokers respectively compared to male
and female never smokers. The association between current
smoking and CHD compared to non-current smoking waseven stronger. The hazard of smoking and HD mortality
or HD events have been studied over the past several de-
cades and the causative relationship between them is well
established [8–12]. However, the effect of smoking on
younger adult’s HD events or mortality has not been well
documented. According to one prospective study, current
smoking was one of the most important predictors of
long-term mortality for CHD patients under age 40 regard-
less of treatment strategy [4]. The harm of current smok-
ing is also higher in younger people than older age groups
as different studies have reported an increased risk of de-
veloping CHD from smoking with decreasing age [11, 12].
Several studies have evaluated the impact of gender
on the relationship between smoking and cardiovascular
events or mortality. Some of them didn’t find any gender
differentiation for young adults [9, 10]. However, all these
studies were case control in design. On the other hand,
several prospective studies emphasized differences by gen-
der with a more harmful effect to women [12, 27, 28]. In
one study, women below age 55 had almost double the
risk for men of below 55 [12]. This difference almost lev-
eled off for the older age groups [12]. A recent review of
26 studies found that, compared with nonsmokers,
women who smoke have a 25 % greater risk of CHD than
a male smokers, independent of other cardiovascular risk
factors [29].
Though not statistically significant, all risk estimates in
the current study were higher in women than in men
and were not affected by adjustment for other major risk
factors. Thus, our results also reinforced the previous
finding that smoking conferred greater risk for women
than men. It is important to note that, this increased risk
among women cannot be explained by the difference in
smoking practice or pattern between men and women
because of evidence from our study and others. First,
compared with men, the prevalence of current smoking
in women was relatively low in our study. The literature
also shows that, though the decline in smoking in young
females has always not followed a linear trend, it was
never higher than young men [30–32]. Second, the num-
ber of cigarettes smoked per day was also lower in
women than men in our study and other national studies
[32]. Finally, it could be argued that if substantially more
men than women gave up smoking during follow up,
that could explain some of the increased risk among
women. We did not calculate information on quitting
smoking. However, according to the estimates of NHIS
2005–2007, more women of age group 18–44 attempted
to quit smoking in the past one year rather than men of
the same age group. Thus, if the increased risk were due
to smoking pattern of the individual, male smokers
would have a greater risk of CHD than female smokers,
which is contrary to the findings of our analysis and
findings from other prospective studies [12, 27, 28].
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current smokers had higher risk for CHD than male
current smokers independent of other cardiovascular
risk factors and individual’s smoking pattern, suggesting
differences in mechanism of action of tobacco in men
and women even at a young age. A possible cause of the
sex difference could be an interaction of oestrogen hor-
mone with components of the tobacco. Epidemiological
evidence suggests that women who smoke are relatively
deficient in oestrogen as constituents of tobacco smoke
exert antioestrogenic effects [33, 34]. Thus the hormonal
benefit of premenopausal women are reduced and oxida-
tion of low-density lipoprotein (LDL) cholesterol in
smokers is thus hampered [35]. This may increase the
level of LDL cholesterol and decrease the level of high
density lipoprotein (HDL) cholesterol [36]. Another
possible explanation could be the presence of smaller
coronary arteries than men [37]. As a result, smaller
thrombus might be required for coronary occlusion in
women, and thus the thrombogenic effects of smoking is
magnified [38, 39]. These differences can also be a re-
flection of the overall gender disparity in receiving med-
ical care for heart disease [40, 41].
We found both HD and CHD mortality to be strongly
associated with current smoking only, and the magnitude
of the risk is diminished with past smoking. This supports
the benefits of quitting smoking. This is in agreement with
findings from many previous studies that showed that
smoking cessation reduced the risk of subsequent mortality
and further cardiac events [42–45]. There has been de-
bate as to the speed and magnitude of risk reduction of
mortality when a smoker quits. Some studies found a
meaningful reduction in risk after only 2 to 3 years [42, 44].
Some of the studies suggest that risk can decline to that of
a lifelong nonsmoker [44, 45]. A systematic review of
23 prospective studies from different parts of the world
strongly suggests that quitting smoking can reduce CHD
mortality by 36 % [46]. They found this risk reduction rela-
tively consistent, regardless of the factors like age or study
population [46]. They also concluded that stopping smok-
ing may have a greater effect on reducing the risk of mor-
tality among patients with CHD who smoke than the effect
of any other intervention or treatment [46].
A few limitations of our study need to be addressed. We
assessed smoking status of individuals only at baseline.
We were not able to get the updated smoking status of
the participants over time. That is, some of our non-
smokers might have had started to smoke as they were
very young. It is also possible that some of our current
smokers quit smoking and would have been classified as
past smokers. Thus our study might have underestimated
the risk as a recent study observed stronger associations
of smoking with HD mortality when using updated infor-
mation on smoking status [47]. We also were not able tocalculate the effect of passive smoking on HD mortal-
ity. Individuals described as non-smokers could be at
increased risk due to passive smoking, even if only oc-
casionally exposed [48]. This also might lead us to an
underestimation of the true risk. Another issue to be
mentioned is, we had a small number of CHD deaths
among never and past smoker categories and the cat-
egories were combined to provide more stable HR and
SAF estimates. We acknowledge here the possibility of
HR and SAF being underestimated by collapsing these
groups and using them as reference. We were also not
able to measure the dose response relationship and see
the associations for light smokers versus heavy smokers
due to limited number of deaths in this age group, es-
pecially for females. Finally, we did not have informa-
tion on blood cholesterol, physical activity level and
dietary habits of our participants and we could not
control for them in our multivariable models. This
might have confounded our estimates to some extent.
However, we did control for other stronger cardiovas-
cular risk factor like BMI, hypertension and diabetes
mellitus and believe that our estimates were not af-
fected by them.
Conclusion
The results of this longitudinal analysis come from a
representative sample and thus may be generalized to
the U.S. population. We showed a strong relationship
between smoking and HD mortality among young adults
that is likely causal. The results also showed that smok-
ing was more harmful to women than men with regard
to HD deaths. As the precise mechanism for this risk
difference between men and women is unclear, our re-
sults suggest the need for more exploratory study into
the pathophysiology of HD, particularly CHD among
younger women. Our results also emphasize that inclu-
sion of a female perspective in smoking control policies
is essential even among the young adults. It is also rec-
ommended that effective interventions should target
young adults and should not only be directed towards
preventing smoking initiation. People should also know
the benefits of quitting and they should be encouraged
to quit smoking at an early age.
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